13
Myocardial Protection for correction of AV Canal Defect Ron Angona, MS, CCP University of Rochester Medical Center Rochester, NY

Myocardial Protection for correction of AV Canal Defect Ron Angona, MS, CCP University of Rochester Medical Center Rochester, NY

Embed Size (px)

Citation preview

Page 1: Myocardial Protection for correction of AV Canal Defect Ron Angona, MS, CCP University of Rochester Medical Center Rochester, NY

Myocardial Protection for correction of AV Canal Defect

Ron Angona, MS, CCP

University of Rochester Medical CenterRochester, NY

Page 2: Myocardial Protection for correction of AV Canal Defect Ron Angona, MS, CCP University of Rochester Medical Center Rochester, NY

• None

Disclosures

Page 3: Myocardial Protection for correction of AV Canal Defect Ron Angona, MS, CCP University of Rochester Medical Center Rochester, NY

• 2 y.o. w/ AV canal defect, Trisomy 21– Admitted from home

• Balanced canal, moderate atrial component with small ventricular component completely occluded by tricuspid valve

• Mild MR, cleft MV, nl LV fxn

– 85cm, 10 kg BSA 0.49 m2

– Bicaval cannulation– antegrade cardioplegia

Background

Page 4: Myocardial Protection for correction of AV Canal Defect Ron Angona, MS, CCP University of Rochester Medical Center Rochester, NY

• Initial dose typically 40-60 mL/kg• 4:1 Blood:Crystalloid

– Crystalloid solution is Plasmalyte-A w/ 52.8 meq K+ added– Made in house by pharmacy– No additives– Single dose in 95% of cases

• Essentially all but ASO

– Up to 100 minute x-clamp times

• Arrest typically occurs at 5mL/kg

Myocardial Protection

Page 5: Myocardial Protection for correction of AV Canal Defect Ron Angona, MS, CCP University of Rochester Medical Center Rochester, NY

• Cardioplegia initiated• Delayed arrest (mostly) occurred around 10 mL/kg

• Rapid investigation– Is the crystalloid bag opened?– Is the plegia cold?– Good root pressure– Ratio set correctly at 4:1– Correct tubing sizes

– Potassium?

Continued…

Page 6: Myocardial Protection for correction of AV Canal Defect Ron Angona, MS, CCP University of Rochester Medical Center Rochester, NY

• Sample of crystalloid cardioplegia solution taken, run on ABG analyzer

• Concurrently, (at about ~20 mL/kg) surgeon asks:

“Did you put potassium in the cardioplegia?”

Run a Sample

Page 7: Myocardial Protection for correction of AV Canal Defect Ron Angona, MS, CCP University of Rochester Medical Center Rochester, NY

• K+ in plegia bag should be out of range– Actual value of sample was 4.6 mmol/L

• Call another perfusionist– Double check observations

• Plegia dose finishes at 55 mL/kg– Surgeon icing heart, concerned

• Sample off plegia heat exchanger (post-mix), completed after dose finished, showed HCT 14%, K+ 3.8.– Pt. K+ at this time was 3.8, K+ in Normosol is 4.6…

Results

Page 8: Myocardial Protection for correction of AV Canal Defect Ron Angona, MS, CCP University of Rochester Medical Center Rochester, NY

• Sample run from another bag of plegia showed a k+ of 15, as would be expected

• Stuck needle in line when we took back the plegia, K+ again was 3.8– We questioned the composition of the blood of the top of

the heat exchanger– Early Resumption of Activity

• Pharmacist called• Plegia bag sequestered, samples sent to pharmacy

More Samples…

Page 9: Myocardial Protection for correction of AV Canal Defect Ron Angona, MS, CCP University of Rochester Medical Center Rochester, NY
Page 10: Myocardial Protection for correction of AV Canal Defect Ron Angona, MS, CCP University of Rochester Medical Center Rochester, NY

• Pharmacy verified the mistake that evening– Several bags effected no others had been used

• Pump time 1:36, x-clamp 1 hour (55 min ischemic time)

• Normal resumption of activity• Pt. weaned from CPB on expected regiment of Epi

(0.03), Dopa (3), Milrinone (0.5)• To PICU intubated

Findings, Results

Page 11: Myocardial Protection for correction of AV Canal Defect Ron Angona, MS, CCP University of Rochester Medical Center Rochester, NY

• Extubated following morning 9am to NC 2L– Lactate nl, Epi + Dopa off by that point– Peak troponin 0.36, lactate 1.8,

• POD 2 – milrinone off, ambulates, PO diet– CK Peak 2090, CKMB 44.9

• Sedated ECHO POD 9 – nothing significant• Delayed discharge (POD 10) d/t continued drainage

from MT tube– Uneventful otherwise

• 1 month f/u – no limitations, no cardiac meds

Post Op

Page 12: Myocardial Protection for correction of AV Canal Defect Ron Angona, MS, CCP University of Rochester Medical Center Rochester, NY

• Could have added more K+– Time constraint

• Second dose of cardioplegia• Plegia now made in OR by perfusion

– Mix is tested prior to clamping, administration • Temporary?• Liability?

Process Improvement / Fall out

Page 13: Myocardial Protection for correction of AV Canal Defect Ron Angona, MS, CCP University of Rochester Medical Center Rochester, NY

• Sentinel events can make you question even your most basic assumptions

• Very fortunate patient was unharmed

• How important is cardioplegia composition in PEDIATRIC cardiac surgery?

– Cardioplegia in Pediatric Cardiac Surgery: Do We Believe in Magic? Doenst T

Ann Thorac Surg 2003;75:1668-77

Conclusion